Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biol Pharm Bull ; 29(7): 1466-9, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16819190

RESUMEN

We examined region-dependent differences and alterations in the levels of protective thiol compounds, glutathione (GSH) and metallothionein (MT)-I and -II, in cultured rat astrocytes under several culture conditions and in brain tissues of rats at postnatal and weaning periods. Regardless of culture conditions, both protein concentrations and mRNA expressions of MT-I and -II were much higher in the cerebral hemisphere than in cerebellar astrocytes, whereas no difference was observed in GSH concentration. In both astrocytes, the GSH concentrations did not change within 12 h but significantly increased 24 h after being maintained in a serum-free defined medium. At 24 h, protein concentrations and mRNA expressions of MT-I and -II also increased in the respective astrocytes, and were further enhanced when maintained in the presence of 50 microM Zn(2+). In the brain tissues, the MT-I/-II protein concentrations were significantly higher in the cerebral cortex (a part of the cerebral hemisphere) than in the cerebellum, whereas the GSH concentration was similar at both postnatal day (P)1 and P35. In addition, the concentrations in the respective regions were significantly higher at P35 than at P1. These results suggest that region-dependent differences in the cellular levels of GSH and MTs in cultured astrocytes might reflect the in vivo differences, and that the levels of the respective thiol compounds in cultured astrocytes increase after serum elimination along with the region-dependent differences.


Asunto(s)
Astrocitos/metabolismo , Encéfalo/metabolismo , Compuestos de Sulfhidrilo/metabolismo , Animales , Animales Recién Nacidos , Células Cultivadas , Femenino , Glutatión/metabolismo , Cinética , Masculino , Metalotioneína/metabolismo , Ratas , Ratas Wistar
2.
Biol Pharm Bull ; 28(12): 2308-11, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16327170

RESUMEN

We investigated acute cytotoxic effects and Hg accumulation after exposure to methylmercury (MeHg) or Hg(2+) in the presence or absence of serum in cultured astrocytes prepared from the cerebral hemisphere or cerebellum of newborn rats. Dose-related changes in viable cell numbers after exposure to mercuric compounds were not different between astrocytes from both regions under the specified conditions. Accumulation of each compound for 3 h was similar in both astrocytes but that for 24 h became different, especially that of Hg(2+). In both astrocytes, susceptibility to the respective compounds was higher in the order of those exposed immediately after, without, and 24 h after changing the serum-containing medium to a serum-free defined medium (SFDM). Accumulation for 3 h was higher in the respective astrocytes exposed to MeHg or Hg(2+) immediately after being maintained in SFDM than in those exposed 24 h after. These results suggest that accumulation of mercuric compounds up to 3 h strongly correlates with susceptibility, at least when maintained in SFDM. Astrocytic morphology changed to a satellite shape after the medium change to SFDM particularly in cerebellar astrocytes but only a few in cerebral hemisphere astrocytes, and it was reverted to a polygonal shape by MeHg but not Hg(2+) at 3 microM. The present results suggest that although some properties such as morphological changes and Hg accumulation are different between cerebral hemisphere and cerebellar astrocytes, these differences are not simply reflected by susceptibility to the acute cytotoxicity of mercuric compounds.


Asunto(s)
Astrocitos/efectos de los fármacos , Cerebelo/citología , Corteza Cerebral/citología , Cloruro de Mercurio/toxicidad , Compuestos de Metilmercurio/toxicidad , Animales , Animales Recién Nacidos/anatomía & histología , Astrocitos/patología , Astrocitos/ultraestructura , Forma de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Cerebelo/química , Cerebelo/efectos de los fármacos , Corteza Cerebral/química , Corteza Cerebral/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Embarazo , Ratas , Ratas Wistar , Distribución Tisular , Pruebas de Toxicidad Aguda/métodos
3.
J Urol ; 173(5): 1762-6, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15821583

RESUMEN

PURPOSE: Hypoxia-inducible factor-1alpha (HIF-1alpha) is a transcriptional factor that regulates genes involved in the response to hypoxia. We evaluated the effects of HIF-1alpha over expression on the tumorigenic potency of renal cell carcinoma VMRC cells and bladder cancer EJ cells in vitro and in vivo. MATERIALS AND METHODS: We introduced HIF-1alpha expression vectors into VMRC and EJ cells, and generated the HIF-1alpha over expressing cell lines VMRC-HIF1alpha and EJ-HIF1alpha, and the vector only transfected cell lines VMRC-neo and EJ-neo. We then evaluated in vitro cell proliferation and in vivo tumor growth of these cell lines after subcutaneous injection into athymic nude mice. RESULTS: In vitro studies showed that HIF-1alpha over expression in VMRC and EJ cells accelerated cell proliferation during the confluent growth phase and rendered these cells resistant to hypoxic stress. Furthermore, in vivo studies revealed that all 4 types of cancer cells (VMRC-neo, VMRC-HIF1alpha, EJ-neo and EJ-HIF1alpha) formed tumors in nude mice and the size of VMRC-HIF1alpha cell derived xenografts was much larger than that of VMRC-neo cell derived xenografts. Although HIF-1alpha over expression did not affect the size of EJ cell derived xenografts, histological examination showed that there was only a small area of necrosis in EJ-HIF1alpha cell derived xenografts, whereas a large area of central necrosis was observed in EJ-neo cell derived xenografts. It was also found that HIF-1alpha over expression increased intratumor microvessel density in the xenografts. CONCLUSIONS: These results suggest that HIF-1alpha may have important roles in bladder and renal cancer angiogenesis and proliferation.


Asunto(s)
Proteínas de Unión al ADN/biosíntesis , Neoplasias Renales/metabolismo , Proteínas Nucleares/biosíntesis , Factores de Transcripción/biosíntesis , Neoplasias de la Vejiga Urinaria/metabolismo , Regulación Neoplásica de la Expresión Génica , Humanos , Factor 1 Inducible por Hipoxia , Subunidad alfa del Factor 1 Inducible por Hipoxia , Neoplasias Renales/genética , Neoplasias Renales/patología , Células Tumorales Cultivadas , Neoplasias de la Vejiga Urinaria/genética , Neoplasias de la Vejiga Urinaria/patología
4.
Environ Sci ; 12(1): 49-64, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15793560

RESUMEN

Here we present a basic concept and several examples of methods of analysis for chemicals that disrupt cellular signaling pathways, in view of risk assessment for potential endocrine disrupting chemicals (EDCs). The key cellular signaling pathways include 1) ER/coactivator interaction, 2) AR translocation into the nucleus, 3) ER/NO/sGC/cGMP, 4) ER/Akt, 5) ER/Src, 6)ER/Src/Grb2, and 7) ER/Ca2+/CaM/CaMK pathways. These were visualized in relevant live cells using newly developed fluorescent and bioluminescent probes. Changes in cellular signals were thereby observed in nongenomic pathways of steroid hormones upon treatment of the target cells with steroid hormones and related chemicals. This method of analysis appears to be a rational approach to high-throughput prescreening (HTPS) of biohazardous chemicals, EDCs, in particular. Also described was the screening of gene expression by serial analysis of gene expression and gene chips upon applying EDCs to breast cancer cells, mouse livers, and human neuroblastoma NB-1 cells.


Asunto(s)
Sistema Endocrino/efectos de los fármacos , Mediciones Luminiscentes/métodos , Medición de Riesgo , Transducción de Señal/efectos de los fármacos , Esteroides/toxicidad , Animales , Neoplasias de la Mama/patología , Relación Dosis-Respuesta a Droga , Sistema Endocrino/fisiología , Colorantes Fluorescentes , Perfilación de la Expresión Génica , Humanos , Hígado/patología , Ratones , Neuroblastoma/patología , Transducción de Señal/fisiología , Células Tumorales Cultivadas
5.
J Neurosci Res ; 79(5): 608-15, 2005 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-15678513

RESUMEN

Cells prepared from the cerebral hemisphere of embryonic Day 18 rats were maintained for 2 days in serum-free modified Bottenstein-Sato (mBS) medium containing thyroid hormone (TH), with or without leukemia inhibitory factor (LIF) or bone morphogenetic protein (BMP)-2, and these influences on the differentiation and development of glial cells were investigated using the cells maintained in mBS medium containing TH as controls. The levels of glial fibrillary acidic protein (GFAP) expression and the number of GFAP-positive astrocytes increased markedly with the addition of LIF or BMP-2, and were enhanced further with the addition of both LIF and BMP-2. The number of O1-positive oligodendrocytes increased with the addition of LIF, whereas it decreased with the addition of BMP-2. The number did not change with the addition of both cytokines. Using antibody against platelet-derived growth factor (PDGF), we then excluded indirect effects of these cytokines through PDGF, which would increase by accelerated astrocyte development. When PDGF was neutralized, the number of oligodendrocytes increased under all conditions examined. As a result of the neutralization, the effect of BMP-2 on oligodendrocyte differentiation was eliminated, although LIF remained effective. These results suggest that the differentiation of oligodendrocytes was delayed partially by PDGF even in control cultures. It is also suggested that LIF and BMP-2, each of which accelerates the differentiation and development of astrocytes, would seem to have different effects on oligodendrocyte differentiation, i.e., LIF would directly affect oligodendrocyte differentiation, whereas BMP-2 would affect it mainly through PDGF.


Asunto(s)
Proteínas Morfogenéticas Óseas/farmacología , Diferenciación Celular/efectos de los fármacos , Corteza Cerebral/citología , Interleucina-6/farmacología , Neuroglía/efectos de los fármacos , Factor de Crecimiento Transformador beta/farmacología , Análisis de Varianza , Animales , Anticuerpos/farmacología , Western Blotting/métodos , Proteína Morfogenética Ósea 2 , Recuento de Células/métodos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Medios de Cultivo Condicionados/farmacología , Medio de Cultivo Libre de Suero/farmacología , Interacciones Farmacológicas , Embrión de Mamíferos , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica/métodos , Indoles/metabolismo , Factor Inhibidor de Leucemia , Masculino , Neuroglía/citología , Factor de Crecimiento Derivado de Plaquetas/inmunología , Factor de Crecimiento Derivado de Plaquetas/metabolismo , Embarazo , Ratas , Ratas Wistar , Tirosina 3-Monooxigenasa/metabolismo
6.
J Cell Physiol ; 203(3): 529-37, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15521073

RESUMEN

Thioredoxin reductase (TrxR) is a selenoprotein that catalyzes the reduction of the active site disulfide of thioredoxin (Trx), which regulates the redox status of the cells. In the present study, we found that TrxR1, one of the three TrxR isozymes, was induced by cadmium as well as tumor necrosis factor alpha (TNFalpha) in bovine arterial endothelial cells (BAEC), and investigated the mechanism of cadmium-induced TrxR1 expression. We here showed that cadmium, differently from TNFalpha, enhanced the promoter activity of the 5'-flanking region of human TrxR1 gene (nucleotides -1692 to +49). Deletion and site-directed mutation of antioxidant responsive element (ARE) (nucleotides -62 to -48) in this region abolished the response to cadmium. Overexpression of NF-E2-related factor-2 (Nrf2) augmented the TrxR1 promoter activity. In contrast, overexpression of the dominant negative mutant of Nrf2 suppressed cadmium-induced activation of TrxR1 promoter through the ARE. Chromatin immunoprecipitation (ChIP) assays showed that anti-Nrf2 antibody precipitated ARE from the chromatin of the cadmium-treated cells. These results indicated that cadmium-induced TrxR1 gene expression is mediated by the activation of Nrf2 transcription factor and its binding to ARE in the TrxR1 gene promoter. We further found that in addition to cadmium, the activators of Nrf2, such as diethyl maleate (DEM) and arsenite, induced both TrxR1 and Trx gene expression in BAEC. Nrf2 might play an important role in the regulation of the cellular Trx system consisting of Trx and TrxR.


Asunto(s)
Cadmio/farmacología , Proteínas de Unión al ADN/metabolismo , Células Endoteliales/metabolismo , Genes Reguladores/genética , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Transactivadores/metabolismo , Región de Flanqueo 5'/efectos de los fármacos , Región de Flanqueo 5'/genética , Animales , Arsenitos/farmacología , Bovinos , Línea Celular , Proteínas de Unión al ADN/genética , Células Endoteliales/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/genética , Genes Reguladores/efectos de los fármacos , Humanos , Malatos/farmacología , Mutagénesis Sitio-Dirigida/genética , Mutación/genética , Factor 2 Relacionado con NF-E2 , Regiones Promotoras Genéticas/efectos de los fármacos , Regiones Promotoras Genéticas/genética , Tiorredoxina Reductasa 1 , Reductasa de Tiorredoxina-Disulfuro/efectos de los fármacos , Reductasa de Tiorredoxina-Disulfuro/genética , Transactivadores/genética , Activación Transcripcional/efectos de los fármacos , Activación Transcripcional/genética , Factor de Necrosis Tumoral alfa/farmacología , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genética
7.
J Neurochem ; 90(3): 750-7, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15255954

RESUMEN

Regulation of astrocyte differentiation is a key process in the development of the central nervous system (CNS), and disturbance of the differentiation can lead to brain system dysfunction. Here we show that beta-naphthoflavone (betaNF), an agonist of the aryl hydrocarbon receptor (AhR), disturbed the cAMP-induced astrocytic differentiation of C6 glioma by inhibiting autocrine interleukin-6 (IL-6). Treatment of cells with betaNF reduced the induction of an astrocyte marker glial fibrillary acidic protein (GFAP). This was caused by the inactivation of its upstream transcription factor signal transducer and activator of transcription 3 (STAT3) by betaNF. In addition, betaNF attenuated the induction of the IL-6 gene, which leads to the activation of STAT3. Most importantly, the inhibitory effect of betaNF on GFAP promoter activity was recovered by the addition of recombinant IL-6. Taken together, these results indicate that the inhibitory effect of betaNF on IL-6 induction suppresses STAT3 activation. These processes subsequently lead to the attenuation of GFAP induction.


Asunto(s)
Astrocitos/citología , Comunicación Autocrina/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Glioma/metabolismo , Interleucina-6/metabolismo , beta-naftoflavona/farmacología , Animales , Bucladesina/farmacología , Línea Celular Tumoral , Proteínas de Unión al ADN/efectos de los fármacos , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Proteína Ácida Fibrilar de la Glía/genética , Proteína Ácida Fibrilar de la Glía/metabolismo , Glioma/tratamiento farmacológico , Ratas , Receptores de Hidrocarburo de Aril/agonistas , Factor de Transcripción STAT3 , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Teofilina/farmacología , Transactivadores/efectos de los fármacos , Transactivadores/metabolismo
8.
Free Radic Biol Med ; 37(3): 350-7, 2004 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-15223068

RESUMEN

To determine the mechanism of 2,4,6-trinitrotoluene (TNT)-induced oxidative stress involving neuronal nitric oxide synthase (nNOS), we examined alterations in enzyme activity and gene expression of nNOS by TNT, with an enzyme preparation and rat cerebellum primary neuronal cells. TNT inhibited nitric oxide formation (IC(50) = 12.4 microM) as evaluated by citrulline formation in a 20,000 g cerebellar supernatant preparation. A kinetic study revealed that TNT was a competitive inhibitor with respect to NADPH and a noncompetitive inhibitor with respect to L-arginine. It was found that purified nNOS was capable of reducing TNT, with a specific activity of 3900 nmol of NADPH oxidized/mg/min, but this reaction required CaCl(2)/calmodulin (CaM). An electron spin resonance (ESR) study indicated that superoxide (O(2)(.-)) was generated during reduction of TNT by nNOS. Exposure of rat cerebellum primary neuronal cells to TNT (25 microM) caused an intracellular generation of H(2)O(2), accompanied by a significant increase in nNOS mRNA levels. These results indicate that CaM-dependent one-electron reduction of TNT is catalyzed by nNOS, leading to a reduction in NO formation and generation of H(2)O(2) derived from O(2)(.-). Thus, it is suggested that upregulation of nNOS may represent an acute adaptation to an increase in oxidative stress during exposure to TNT.


Asunto(s)
Regulación Enzimológica de la Expresión Génica , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico/biosíntesis , Estrés Oxidativo , Trinitrotolueno/química , Trinitrotolueno/metabolismo , Animales , Células Cultivadas , Cerebelo/citología , Cerebelo/metabolismo , Electrones , Peróxido de Hidrógeno/metabolismo , Masculino , Proteínas del Tejido Nervioso/antagonistas & inhibidores , Proteínas del Tejido Nervioso/aislamiento & purificación , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/aislamiento & purificación , Óxido Nítrico Sintasa de Tipo I , Oxidación-Reducción , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo
9.
J Neurosci Res ; 76(3): 423-33, 2004 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-15079872

RESUMEN

We examined the effects of bisphenol A, an endocrine disruptor, on rat behavioral and cellular responses. Single intracisternal administration of bisphenol A (0.2-20 microg) into 5-day-old male Wistar rats caused significant hyperactivity at 4-5 weeks of age. Rats were about 1.6-fold more active in the nocturnal phase after administration of both 2 and 20 microg of bisphenol A than were control rats. The response was dose-dependent. Based on DNA macroarray analyses of the midbrain, bisphenol A decreased by more than twofold gene expression levels of the dopamine D4 receptor at 4 weeks of age and the dopamine transporter at 8 weeks of age. Furthermore, bisphenol A decreased by more than twofold gene expression levels of the dopamine D4 receptor at 4 weeks of age and the dopamine transporter at 8 weeks of age. We conclude that bisphenol A affected central dopaminergic system activity, resulting in hyperactivity due most likely to a large reduction of tyrosine hydroxylase activity in the midbrain.


Asunto(s)
Estrógenos no Esteroides/administración & dosificación , Hipercinesia/inducido químicamente , Glicoproteínas de Membrana , Proteínas de Transporte de Membrana/efectos de los fármacos , Proteínas del Tejido Nervioso/efectos de los fármacos , Fenoles/administración & dosificación , Receptores de Dopamina D2/efectos de los fármacos , Tirosina 3-Monooxigenasa/efectos de los fármacos , Factores de Edad , Animales , Compuestos de Bencidrilo , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática , Relación Dosis-Respuesta a Droga , Femenino , Hipercinesia/metabolismo , Inyecciones Intraventriculares , Masculino , Proteínas de Transporte de Membrana/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Ratas , Ratas Wistar , Receptores de Dopamina D2/metabolismo , Receptores de Dopamina D4 , Espacio Subaracnoideo , Tirosina 3-Monooxigenasa/metabolismo
10.
Biochem Biophys Res Commun ; 317(1): 84-91, 2004 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-15047151

RESUMEN

The hypoxia-inducible factors 1alpha (HIF-1alpha) and 2alpha (HIF-2alpha) have extensive structural homology and have been identified as transcription factors that mediate hypoxia-inducible gene expression through hypoxia-responsive element (HRE). They play critical roles not only in normal development, but also in tumor progression. Endothelial cells (EC) express both HIF-1alpha and -2alpha. In this study, we examined the subcellular localization of HIF-1alpha and -2alpha in bovine arterial EC (BAEC) by immunoblotting and immunocytostaining analysis and found that even under normoxic conditions, as with its heterodimeric partner ARNT, HIF-2alpha was stable, and was localized in the nucleus of BAEC differently than HIF-1alpha. HIF-2alpha might be regulated by a different mechanism than HIF-1alpha and might mediate the expression of some EC-specific genes under normoxic conditions. We further found that cardiovascular helix-loop-helix factor (CHF) 2, which had been identified as an ARNT-interacting protein, was expressed in BAEC and suppressed HRE-dependent gene expression both under normoxia and hypoxia. CHF2 might be one of the key regulators of HIF-2alpha-mediated gene expression in normoxic EC.


Asunto(s)
Proteínas de Unión al ADN , Endotelio Vascular/metabolismo , Factores de Transcripción/metabolismo , Secuencia de Aminoácidos , Animales , Arterias/citología , Arterias/metabolismo , Translocador Nuclear del Receptor de Aril Hidrocarburo , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico , Bovinos , Hipoxia de la Célula/genética , Endotelio Vascular/citología , Regulación de la Expresión Génica , Subunidad alfa del Factor 1 Inducible por Hipoxia , Luciferasas/metabolismo , Datos de Secuencia Molecular , Receptores de Hidrocarburo de Aril/genética , Receptores de Hidrocarburo de Aril/metabolismo , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Elementos de Respuesta/genética , Fracciones Subcelulares/metabolismo , Factores de Transcripción/genética , Transcripción Genética , Transfección , Xenobióticos
11.
J Biol Chem ; 279(15): 15441-7, 2004 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-14754894

RESUMEN

Elevation in the level of intracellular cAMP is known to induce the astrocytic differentiation of C6 glioma cells by unknown mechanisms. In this report, we show that cAMP-induced autocrine interleukin 6 (IL-6) promoted astrocytic differentiation of C6 cells. Treatment of cells with N(6),2'-O-dibutyryl cAMP (Bt(2)AMP) and theophylline caused the delayed phosphorylation of signal transducer and activator of transcription 3 (STAT3), as well as the expression of an astrocyte marker, glial fibrillary acidic protein (GFAP). Overexpression of the dominant-negative form of STAT3 leads to the suppression of GFAP promoter activity, suggesting that STAT3 activity was essential for cAMP-induced GFAP promoter activation. On the other hand, the IL-6 gene was quickly induced by Bt(2)AMP/theophylline, and subsequent IL-6 protein secretion was stimulated. In addition, recombinant IL-6 induced GFAP expression and STAT3 phosphorylation. Most importantly, treatment with IL-6-neutralizing antibody dramatically reduced the cAMP-induced GFAP expression and STAT3 phosphorylation and reversed the cellular morphological changes that had been caused by Bt(2)AMP/theophylline. Taken together, these results indicated that Bt(2)AMP/theophylline lead to delayed STAT3 activation via autocrine IL-6. These processes subsequently led to the induction of GFAP. IL-6 secretion is thus thought to be a key event in controlling the astrocytic differentiation of C6 cells.


Asunto(s)
Astrocitos/citología , AMP Cíclico/metabolismo , Glioma/metabolismo , Interleucina-6/fisiología , Sulfonamidas , Animales , Astrocitos/metabolismo , Western Blotting , Neoplasias Encefálicas/metabolismo , Bucladesina/metabolismo , Diferenciación Celular , Línea Celular Tumoral , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Proteínas de Unión al ADN/metabolismo , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Ensayo de Inmunoadsorción Enzimática , Genes Reporteros , Proteína Ácida Fibrilar de la Glía/metabolismo , Interleucina-6/metabolismo , Isoquinolinas/farmacología , Microscopía Fluorescente , Modelos Biológicos , Fosforilación , Plásmidos/metabolismo , Regiones Promotoras Genéticas , Ratas , Proteínas Recombinantes/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Transcripción STAT3 , Teofilina/farmacología , Factores de Tiempo , Transactivadores/metabolismo , Transcripción Genética
12.
J Cell Physiol ; 198(1): 22-30, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14584040

RESUMEN

Thioredoxin reductase (TrxR) is a flavoprotein that contains a C-terminal penultimate selenocysteine (Sec) and has an ability to reduce thioredoxin (Trx), which regulates the activity of NF-kappa B. To date, three TrxR isozymes, TrxR1, TrxR2, and TrxR3, have been identified. In the present study, we found that among these isozymes only TrxR1 was induced by tumor necrosis factor-alpha (TNF alpha) in vascular endothelial cells. Furthermore, the overexpression of TrxR1 enhanced TNF alpha-induced DNA-binding activity of NF-kappa B and NF-kappa B-dependent gene expression. The catalytic Sec residue of TrxR1, which is essential for reducing Trx, was required for this NF-kappa B activation, and aurothiomalate, an inhibitor of TrxR, suppressed TNF alpha-induced activation of NF-kappa B and the expression of NF-kappa B-targeted proinflammatory genes such as E-selectin and cyclooxygenase-2. These results suggest that TrxR1 may act as a positive regulator of NF-kappa B and may play an important role in the cellular inflammatory response.


Asunto(s)
Isoenzimas/metabolismo , FN-kappa B/metabolismo , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Animales , Antirreumáticos/metabolismo , Bovinos , Células Cultivadas , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Regulación de la Expresión Génica , Tiomalato Sódico de Oro/metabolismo , Humanos , Isoenzimas/genética , Hígado/metabolismo , Ratones , Tiorredoxina Reductasa 1 , Reductasa de Tiorredoxina-Disulfuro/genética , Factor de Necrosis Tumoral alfa/metabolismo
13.
J Neurosci Res ; 73(6): 831-9, 2003 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-12949909

RESUMEN

The 440-kDa isoform of brain ankyrin, 440-kDa ankyrinB, is a neuron-specific protein and is confined to axons. Cerebellum is one of the areas characteristically altered by methylmercury intoxication both in the adult and during development. When rat cerebellar neurons matured for 7 days in vitro were exposed to methylmercury at 0.03 microM for 48 hr, viability of the cells was unaffected. However, the immunocytochemical staining of 440-kDa ankyrinB diminished drastically, whereas that of microtubule-associated protein-2, which is localized in dendrites and cell bodies, and of glial fibrillary acidic protein (GFAP), a marker for astroglial cells coexisting in the culture, remained unchanged. To confirm these observations, a simplified dot blot assay was established to determine 440-kDa ankyrinB and several other marker proteins in cultured cell samples. With this assay, we found that methylmercury at a submicromolar range induced a decrease of 440-kDa ankyrinB and an increase of GFAP in a dose-dependent manner in cerebellar cells in primary culture. Surprisingly, another axonal protein, tau, remained mostly in its intact molecular sizes even in the presence of 0.3-1.0 microM methylmercury, though its immunocytochemical localization was substantially altered. These results indicate that selective loss of the axonal protein 440-kDa ankyrinB is associated with the early stage of degeneration of cerebellar neurons induced by methylmercury. Therefore, 440-kDa ankyrinB should be useful as a specific and sensitive marker for the neurotoxicity of methylmercury.


Asunto(s)
Ancirinas/metabolismo , Axones/efectos de los fármacos , Compuestos de Metilmercurio/toxicidad , Degeneración Nerviosa/metabolismo , Animales , Animales Recién Nacidos , Axones/metabolismo , Western Blotting , Células Cultivadas , Cerebelo/citología , Cerebelo/efectos de los fármacos , Cerebelo/metabolismo , Relación Dosis-Respuesta a Droga , Proteína Ácida Fibrilar de la Glía/metabolismo , Immunoblotting , Inmunoglobulina G/inmunología , Inmunoglobulina G/metabolismo , Inmunohistoquímica/métodos , Proteínas Asociadas a Microtúbulos/metabolismo , Degeneración Nerviosa/inducido químicamente , Ensayo de Unión Radioligante , Ratas , Ratas Wistar , Factores de Tiempo
14.
J Neurosci Res ; 69(1): 61-71, 2002 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-12111816

RESUMEN

The influence of cell density and thyroid hormone (TH) on the development of astrocytes and oligodendrocytes was investigated in primary cultures prepared from rat cerebral hemisphere on embryonic day (E)18. At the beginning of the culture, most of the cells were microtubule-associated protein 2 (MAP2)-positive neurons, whereas O1-positive oligodendrocytes and glial fibrillary acidic protein (GFAP)-positive astrocytes were rarely observed. After the cells were maintained in serum-free defined medium, astrocytes developed at high cell density but rarely at a low one. When leukemia inhibitory factor (LIF) was supplemented in low-density cultures, the levels of GFAP expression markedly increased to almost the same extent as in high-density culture without TH. This suggests that, in low-density cultures, astrocyte progenitors could not differentiate because of insufficient astrocyte-inducing factors. Interestingly, the addition of TH increased GFAP expression levels only at high density. The number of oligodendrocytes increased with TH addition at both cell densities, although the effects were more remarkable at high density. These results suggest that cell density and TH are pivotal factors in the development of both astrocytes and oligodendrocytes. It is also suggested that the effects of TH on glial cell development could be accelerated via cell-cell communications.


Asunto(s)
Corteza Cerebral/efectos de los fármacos , Neuroglía/citología , Neuroglía/efectos de los fármacos , Hormonas Tiroideas/farmacología , Animales , Recuento de Células/métodos , Recuento de Células/estadística & datos numéricos , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Células Cultivadas , Corteza Cerebral/citología , Corteza Cerebral/metabolismo , Embrión de Mamíferos , Femenino , Proteína Ácida Fibrilar de la Glía/biosíntesis , Masculino , Neuroglía/metabolismo , Ratas , Ratas Wistar , Hormonas Tiroideas/metabolismo
15.
Environ Health Perspect ; 110(1): 37-42, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11781163

RESUMEN

We examined the effects of cadmium on the bcl-2 family of proteins--bcl-2, bax, bad, and bcl-xS/L--in cadmium-induced cytotoxicity. Addition of 10 microM cadmium to cultured porcine kidney LLC-PK(1) cells caused apoptosis. Western blot analyses revealed that cadmium markedly increased endogenous bcl-2 protein (to 3-4 times the level in wild-type cells) earlier than metallothionein induction, but that the metal did not enhance the induction of bax, bad, or bcl-xS proteins. Cadmium also induced the transcript of bcl-2, with the amount of bcl-2 reaching a maximum at 1-2 hr of exposure; this increase occurred earlier than cadmium-induced increase in the protooncogene such as c-myc. A cadmium-induced increase in endogenous bcl-2 protein was also seen in rat primary thymocytes. Overexpression of the bcl-2 protein by gene transfection prevented cadmium-induced apoptosis. Following the detection of apoptosis, lactate dehydrogenase release in the culture medium (a marker of necrosis) was observed, and this release was also inhibited by overexpression of bcl-2. Electron microscopic observations also supported the fact that cadmium induced apoptotic chromatin condensation at an early stage of exposure, followed by necrotic features of the cells, both of which were also inhibited by overexpression of bcl-2 proteins. Thus, our data demonstrated that both apoptotic and necrotic actions of cadmium were attenuated by bcl-2.


Asunto(s)
Apoptosis/efectos de los fármacos , Cadmio/efectos adversos , Contaminantes Ambientales/efectos adversos , Genes bcl-2 , Proteínas Proto-Oncogénicas c-bcl-2/biosíntesis , Animales , Western Blotting , Técnicas de Cultivo de Célula , Riñón/citología , Riñón/efectos de los fármacos , Riñón/patología , L-Lactato Deshidrogenasa/metabolismo , Microscopía Electrónica , Necrosis , Proteínas Proto-Oncogénicas c-bcl-2/farmacología , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA